Abstract
Pfizer is a multinational pharmaceutical company that specializes in the research, development, manufacturing, marketing, and sale of pharmaceuticals. When it comes to the pharmaceutical industry, Pfizer is a major player, and it has developed phase-3 study COVID-19 vaccine on November 9, 2020, which provided a positive impact on stock prices and distinguishes Pfizer stock price trends from other companies. This research focus on the Pfizer stock price which comes from Yahoo Finance website to compare difference model performance of Pfizer stock price forecasting and test if the stock market’s trend before and after the COVID-19 outbreak is distinct. The result shows the LSTM had a best performance and in the next year, Pfizer stock price will stay at around 43 after a sharp decrease. And the vaccine has a statistically significant effect on the stock price. This essay provides a forecast regarding the pattern of recovery throughout the period after the COVID-19 pandemic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alkhyeli, S., et al.: Financial analysis and performance evaluation of Pfizer. Available at SSRN 3896385 (2021)
Aggarwal, R.K., Wu, G.: Stock market manipulations. J. Bus. 79(4), 1915–1953 (2006)
Kapar, B., Buigut, S., Rana, F.: Winners and losers from Pfizer and Biontech’s vaccine announcement: evidence from S&P 500 (sub) sector indices. PLoS One 17(10), e0275773 (2022)
Baker, S.R., Bloom, N., Davis, S.J., Kost, K.J., Sammon, M.C., Viratyosin, T.: The unprecedented stock market impact of COVID-19 (No. w26945). National Bureau of Economic Research (2020)
Zaremba, A., Kizys, R., Aharon, D.Y., Demir, E.: Infected markets: novel coronavirus, government interventions, and stock return volatility around the globe. Financ. Res. Lett. 35, 101597 (2020)
Thompson, M.G., et al.: Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—eight US locations, December 2020–March 2021. Morb. Mortal. Weekly Rep. 70(13), 495 (2021)
Bradley, C., Stumpner, P.: The impact of COVID-19 on capital markets, one year in. McKinsey & Company (2021)
Wei, J., Xu, Q., He, C.: Deep learning of predicting closing price through historical adjustment closing price. Procedia Comput. Sci. 202, 379–384 (2022)
Ho, S.L., **e, M.: The use of ARIMA models for reliability forecasting and analysis. Comput. Ind. Eng. 35(1–2), 213–216 (1998)
Weilin, F., et al.: Time series analysis in american stock market recovering in post COVID-19 pandemic period. ar**v preprint ar**v:2212.05369 (2022)
Forecasting: Principles and Practice, 2nd edn. Chapter 8 ARIMA models (n.d.). Accessed 3 Dec 2022
Linden, A., Adams, J.L.: Applying a propensity score-based weighting model to interrupted time series data: improving causal inference in programme evaluation. J. Eval. Clin. Pract. 17(6), 1231–1238 (2011)
Zhou, D., Zheng, L., Zhu, Y., Li, J., He, J.: Domain adaptive multi-modality neural attention network for financial forecasting. In: Proceedings of the Web Conference 2020, pp. 2230–2240 (2020)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Su, R. (2024). Time Series Analysis in Pfizer Stock Prices in the Pre- and Post-COVID-19 Scenarios. In: Li, X., Yuan, C., Kent, J. (eds) Proceedings of the 7th International Conference on Economic Management and Green Development. ICEMGD 2023. Applied Economics and Policy Studies. Springer, Singapore. https://doi.org/10.1007/978-981-97-0523-8_87
Download citation
DOI: https://doi.org/10.1007/978-981-97-0523-8_87
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-97-0522-1
Online ISBN: 978-981-97-0523-8
eBook Packages: Economics and FinanceEconomics and Finance (R0)